September 2019 – Europe has world-class universities, research institutions, medical centers, and hospitals that provide a strong base for sourcing... and developing scientific innovation. However, this strength does not yet translate into patents for new medicines, as Europe trails both China and the United States in that area. Increased investment in biotech may hold the key to helping grow Europe’s share of new drugs. Europe’s biotechs currently receive only 20 percent of the funding their US counterparts do. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”

September 2019 – Europe has a complex biotech landscape, with hundreds of companies, multiple paths to innovation and financing, and marked differences... among countries. To see through the complexity, we grouped approximately 1,000 European biotech companies into eight clusters based on country, modality, and therapeutic area. We identified biotech hot spots as well as trends and possible directions for the region. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”

June 2019 – Medical-device players are venturing into adjacent value pools through solutions and services. What do they require to capitalize... on the opportunity and deliver on their profitable growth aspirations?

June 2019 – To see how the healthcare sector stacks up on gender equality, we look at employee experiences, policies, and the effectiveness... of industry programs intended to promote diversity and inclusion.

Special Collection

As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry. But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights

September 2019 – Europe has world-class universities, research institutions, medical centers, and hospitals that provide a strong base for sourcing... and developing scientific innovation. However, this strength does not yet translate into patents for new medicines, as Europe trails both China and the United States in that area. Increased investment in biotech may hold the key to helping grow Europe’s share of new drugs. Europe’s biotechs currently receive only 20 percent of the funding their US counterparts do. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”

September 2019 – Europe has a complex biotech landscape, with hundreds of companies, multiple paths to innovation and financing, and marked differences... among countries. To see through the complexity, we grouped approximately 1,000 European biotech companies into eight clusters based on country, modality, and therapeutic area. We identified biotech hot spots as well as trends and possible directions for the region. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”

May 2019 – Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical... and complex vaccines could renew the innovation engine.

March 2019 – The Head of Digital Strategy and Medical Innovation, US Clinical Development and Medical Affairs at Novartis discusses how disruptive... technologies and digital innovation are inspiring a start-up mind-set within the organization.

February 2019 – To keep pace with the evolving ecosystem for precision medicine, pharma players must be attuned to three crucial components: data... collection, individualized solutions, and supporting business models.

Related practice

Connect with our Pharmaceuticals & Medical Products Practice

hglwvd.info uses s to improve site functionality, provide you
with a better browsing experience, and to enable our partners to advertise to you. Detailed information on the
use of s on this Site, and how you can decline them, is provided in our policy. By using
this Site or clicking on "OK", you consent to the use of s.